M32-95550-61423
1 vaccination
2 coded responses
12 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 762 / TX
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-15
Registered in v-safe
-
2021-06-15
Dose 1 — Janssen/Johnson & Johnson
- 2021-06-15
-
2021-06-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-17
- 2021-06-18
-
2021-06-19
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-20
- 2021-06-21
- 2021-06-22
- 2021-06-29
-
2021-07-06
Survey response — day 21, single doseMedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Ongoing headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-13
- 2021-07-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-15 | Janssen/Johnson & Johnson |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Cough
Release 9 — day 21, single dose
Symptoms: Ongoing headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release